Biomarker Selection for Maintenance Therapy in Advanced NSCLC
Journal of Clinical Oncology (JCO) Podcast · Journals Online Team
September 29, 20119m 17s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
EGFR mutation is a predictive biomarker for maintenance erlotinib but its clinical application is limited. This podcast will explain why.